Sunny Creek Farm Inc.
Letter data
- Company
- Sunny Creek Farm Inc.
- Recipient
- Lee G. Ewing | President and Owner | Sunny Creek Farm Inc. | 520 Pinefield Drive | Tryon | , | NC | 28782-7795 | United States | Lee.Ewing@sunnycreekfarm.com
- Issue date
- 2022-12-08
- Posted date
- Not available
- FDA office
- Division of Human and Animal Food Operations East III
- Subject
- Not available
- Product
- Food & Beverages
- CMS ID
- 617664
- Reference number
- Not available
- FEI
- Not available
- Inspection dates
- Not available
Normalized citations
21 CFR: None found
21 U.S.C.: None found
Related FDA links
No related FDA letter link is present in the source index.
Full source text
CLOSEOUT LETTER
Sunny Creek Farm Inc.
MARCS-CMS 617664 —
December 08, 2022
More Warning Letters
Warning Letters
About Warning and Close-Out Letters
Delivery Method:
Via Email
Product:
Food & Beverages
Recipient:
Recipient Name
Lee G. Ewing
Recipient Title
President and Owner
Sunny Creek Farm Inc.
520 Pinefield Drive
Tryon
,
NC
28782-7795
United States
Lee.Ewing@sunnycreekfarm.com
Issuing Office:
Division of Human and Animal Food Operations East III
United States
Dear Mr. Ewing:
The Food and Drug Administration has completed evaluation of your firm’s corrective actions in response to our Warning Letter 617664 dated February 2, 2022. We also verified your actions during an FDA inspection that ended September 15, 2022. Based on our evaluation and inspection, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
For questions about this letter, please contact: Stephen J. Rabe, Compliance Officer at: orahafeast3firmresponses@fda.hhs.gov and Stephen.rabe@fda.hhs.gov or by telephone at: 513-322-0660:
Sincerely,
/S/
Stephen J. Rabe
Compliance Officer
Content current as of:
12/12/2022
Regulated Product(s)
Food & Beverages